Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension

被引:10
|
作者
Seki, Mitsuru [1 ,2 ,3 ]
Furukawa, Nozomi [2 ]
Koitabashi, Norimichi [2 ]
Obokata, Masaru [2 ]
Conway, Simon J. [4 ]
Arakawa, Hirokazu [1 ]
Kurabayashi, Masahiko [2 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Pediat, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch Med, Dept Cardiovasc Med, Maebashi, Gunma, Japan
[3] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan
[4] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
来源
PLOS ONE | 2019年 / 14卷 / 08期
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
BONE MORPHOGENETIC PROTEIN; OSTEOBLAST-SPECIFIC FACTOR; SMOOTH-MUSCLE-CELLS; TGF-BETA; RECEPTOR; PROLIFERATION; PROGRESSION; MUTATIONS;
D O I
10.1371/journal.pone.0220795
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transforming growth factor beta (TGF-beta) has been shown to play a critical role in pathogenesis of pulmonary arterial hypertension (PAH) although the precise role of TGF-beta signaling remains uncertain. A recent report has shown that periostin (Pn) is one of the most upregulated proteins in human PAH lung compared with healthy lungs. We established type I TGF-beta receptor knockout mice specifically with Pn expressing cell (Pn-Cre/Tgfb1(fl/fl) mice). Increases in PA pressure and pulmonary artery muscularization were induced by hypoxia of 10% oxygen for 4 weeks. Lung Pn expression was markedly induced by 4 week-hypoxia. Pn-Cre/Tgfb1(fl/fl) mice showed lower right ventricular pressure elevation, inhibition of PA medial thickening. Fluorescent co-immunostaining showed that Smad3 activation in Pn expressing cell is attenuated. These results suggest that TGF-beta signaling in Pn expressing cell may have an important role in the pathogenesis of PAH by controlling medial thickening.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Transforming growth factor β/bone morphogenic protein signaling in pulmonary arterial hypertension:: Remodeling revisited
    Eickelberg, Oliver
    Morty, Rory E.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2007, 17 (08) : 263 - 269
  • [32] Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
    Bandyopadhyay, Abhik
    Agyin, Joseph K.
    Wang, Long
    Tang, Yuping
    Lei, Xiufen
    Story, Beryl M.
    Cornell, John E.
    Pollock, Bradley H.
    Mundy, Gregory R.
    Sun, Lu-Zhe
    CANCER RESEARCH, 2006, 66 (13) : 6714 - 6721
  • [33] Transforming growth factor-β1 protects against pulmonary artery endothelial cell apoptosis via ALK5
    Lu, Qing
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (01) : L123 - L133
  • [34] Pharmacological Inhibition of Epidermal Growth Factor Signaling in Experimental Pulmonary Arterial Hypertension.
    Cornitescu, T.
    Dumitrascu, R.
    Dahal, B.
    Pullamsetti, S. S.
    Ghofrani, H. A.
    Weissmann, N.
    Grimminger, F.
    Seeger, W.
    Schermuly, R. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [35] Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension
    Tojais, Nancy F.
    Cao, Aiqin
    Lai, Ying-Ju
    Wang, Lingli
    Chen, Pin-I
    Alcazar, Miguel A. Alejandre
    Perez, Vinicio A. de Jesus
    Hopper, Rachel K.
    Rhodes, Christopher J.
    Bill, Matthew A.
    Sakai, Lynn Y.
    Rabinovitch, Marlene
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (08) : 1559 - +
  • [36] Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension
    Menon, Divya P.
    Qi, Guanming
    Kim, Seung K.
    Moss, M. Elizabeth
    Penumatsa, Krishna C.
    Warburton, Rod R.
    Toksoz, Deniz
    Wilson, Jamie
    Hill, Nicholas S.
    Jaffe, Iris Z.
    Preston, Ioana R.
    PULMONARY CIRCULATION, 2021, 11 (03)
  • [37] Vps34 Activation Is Pulmonary Vascular Smooth Muscle Cell-specific and Akt-dependent in Pulmonary Arterial Hypertension
    Shen, Y.
    Lin, D.
    Saiyed, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] Transforming growth factor-β signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung
    Ambalavanan, Namasivayam
    Nicola, Teodora
    Hagood, James
    Bulger, Arlene
    Serra, Rosa
    Murphy-Ullrich, Joanne
    Oparil, Suzanne
    Chen, Yiu-Fai
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (01) : L86 - L95
  • [39] Dexlansoprazole prevents pulmonary artery hypertension by inhibiting pulmonary artery smooth muscle cell to fibroblast transition
    Jiao, Qian
    Zou, Fangdi
    Li, Shiliang
    Wang, Jiawen
    Xiao, Yunping
    Guan, Zhihua
    Dong, Liang
    Tian, Jinwei
    Li, Shengqing
    Wang, Rui
    Zhang, Jian
    Li, Honglin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (08): : 5466 - +
  • [40] The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
    Zakrzewicz, A.
    Kouri, F. M.
    Nejman, B.
    Kwapiszewska, G.
    Hecker, M.
    Sandu, R.
    Dony, E.
    Seeger, W.
    Schermuly, R. T.
    Eickelberg, O.
    Morty, R. E.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (06) : 1094 - 1104